Common-Size Income Statement
Paying user area
Try for free
Edwards Lifesciences Corp. pages available for free this week:
- Income Statement
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Balance Sheet: Assets
- Analysis of Short-term (Operating) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Analysis of Geographic Areas
- Common Stock Valuation Ratios
- Total Asset Turnover since 2005
- Price to Sales (P/S) since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Edwards Lifesciences Corp. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Based on: 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31).
Income statement item | Description | The company |
---|---|---|
Operating income | The net result for the period of deducting operating expenses from operating revenues. | Edwards Lifesciences Corp. operating income as a percentage of net sales decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level. |
Income before provision for income taxes | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. | Edwards Lifesciences Corp. income before provision for income taxes as a percentage of net sales decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level. |
Net income | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. | Edwards Lifesciences Corp. net income as a percentage of net sales decreased from 2019 to 2020 but then increased from 2020 to 2021 exceeding 2019 level. |